What hemoglobin thresholds indicate the need for red blood cell transfusion in stable adults, adults with cardiovascular disease or symptomatic anemia, and in pediatric patients including infants, neonates, and preterm infants?

Hemoglobin Transfusion Thresholds

For stable hospitalized adults, transfuse at hemoglobin <7 g/dL; for adults with cardiovascular disease, transfuse at ≤8 g/dL or with symptoms; for stable critically ill children, transfuse at <7 g/dL; and for preterm neonates <30 weeks gestational age, use age- and respiratory support-stratified thresholds ranging from 7-11 g/dL. 1, 2

Adult Populations

Stable Hospitalized Adults (General)

• Use a restrictive transfusion threshold of 7-8 g/dL for hemodynamically stable hospitalized patients, including critically ill patients 1, 2, 3
• This is a strong recommendation with high-quality evidence showing no increased mortality, myocardial infarction, stroke, infection, or thromboembolism with restrictive strategies 1, 3
• The restrictive approach reduces transfusion exposure by 42% without compromising outcomes 4

Surgical Patients

• Orthopedic surgery: transfuse at <8 g/dL or with symptoms (chest pain, orthostatic hypotension/tachycardia unresponsive to fluids, or heart failure) 1, 2, 3
• Cardiac surgery: transfuse at <7.5 g/dL 2, 3
• These thresholds are based on the FOCUS trial which demonstrated safety in high-risk surgical populations 1

Cardiovascular Disease

• For patients with preexisting cardiovascular disease: transfuse at ≤8 g/dL or with symptoms 1, 2
• Symptoms warranting transfusion include: chest pain believed cardiac in origin, orthostatic hypotension or tachycardia unresponsive to fluid resuscitation, or congestive heart failure 1
• This is a weak recommendation with moderate-quality evidence due to limited subgroup data 1

Acute Coronary Syndrome

• No specific threshold can be recommended for hemodynamically stable patients with acute coronary syndrome 1
• The evidence is of very low quality and insufficient to guide practice 1
• Clinical judgment incorporating symptoms and hemodynamic status must guide decisions 1

Gastrointestinal Bleeding

• Use restrictive threshold of 7 g/dL - this population shows mortality benefit with restrictive strategy (RR 0.63) 4

Critical Care Patients

• Transfuse at 7 g/dL based on the landmark TRICC trial 1, 2
• Exception: Neurocritically ill patients may benefit from liberal transfusion strategy (higher thresholds) as they demonstrate better neurological outcomes at 6-12 months with liberal approaches 4

Pediatric Populations

Critically Ill Children (General)

• Transfuse at hemoglobin <7 g/dL for hemodynamically stable critically ill children without hemoglobinopathy, cyanotic cardiac conditions, or severe hypoxemia 2, 5
• This is a strong recommendation with moderate-certainty evidence 2
• Children with sepsis, including septic shock, and those with severe upper GI bleeding do not require transfusion if hemoglobin >7 g/dL 5

Congenital Heart Disease

• Biventricular repair: transfuse at 7 g/dL 2
• Single-ventricle palliation: transfuse at 9 g/dL 2
• Uncorrected congenital heart disease: transfuse at 7-9 g/dL depending on clinical status 2
• These are conditional recommendations with low-certainty evidence 2

Preterm Neonates (<30 Weeks Gestational Age)

Use age-stratified and respiratory support-dependent thresholds 6:

On Respiratory Support (mechanical ventilation, CPAP, or nasal cannula ≥1 L/min):

• Postnatal week 1: transfuse at 11 g/dL 6
• Postnatal week 2: transfuse at 10 g/dL 6
• Postnatal week ≥3: transfuse at 9 g/dL 6

No or Minimal Respiratory Support:

• Postnatal week 1: transfuse at 10 g/dL 6
• Postnatal week 2: transfuse at 8.5 g/dL 6
• Postnatal week ≥3: transfuse at 7 g/dL 6

This is a conditional recommendation with moderate certainty of evidence showing no difference in death or neurodevelopmental impairment at 2 years 6

Important Clinical Caveats

When to Consider Higher Thresholds

• Acute hemorrhage or hemodynamic instability - these recommendations apply only to stable patients 1, 6, 2
• Sepsis or necrotizing enterocolitis in neonates requiring vasopressor/inotropic support 6
• Symptomatic anemia regardless of absolute hemoglobin value 1
• Patients requiring exchange transfusion 6

Populations Excluded from These Recommendations

• Severe thrombocytopenia in hematologic/oncologic patients at bleeding risk 3
• Chronic transfusion-dependent anemia (insufficient evidence) 3
• Patients receiving erythropoiesis-stimulating agents 6

Transfusion Reactions

• Transfusion-specific reactions occur more frequently with liberal strategies (Peto OR 0.47 favoring restrictive) 4
• This supports restrictive approaches from a safety perspective 4